{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:30:33Z","timestamp":1793071833575,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"ANR"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-54054-y","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T07:01:39Z","timestamp":1730962899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["FLT3 signaling inhibition abrogates opioid tolerance and hyperalgesia while preserving analgesia"],"prefix":"10.1038","volume":"15","author":[{"given":"Antoine","family":"Jouvenel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2148-553X","authenticated-orcid":false,"given":"Adrien","family":"Tassou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Thouaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Ruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Antri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Leyris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Giraudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Malli\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chamroeum","family":"Sar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Diouloufet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Sonrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8061-5897","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Daubeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Bertin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Vent\u00e9o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Frossard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Mechaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0577-641X","authenticated-orcid":false,"given":"Didier","family":"Rognan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7129-6043","authenticated-orcid":false,"given":"Pierre","family":"Sokoloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhouane","family":"Dallel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0123-5413","authenticated-orcid":false,"given":"Patrick","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2748-9104","authenticated-orcid":false,"given":"Jean","family":"Valmier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7491-6113","authenticated-orcid":false,"given":"Cyril","family":"Rivat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"54054_CR1","doi-asserted-by":"crossref","unstructured":"Noble, M. et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst. Rev. 2010, CD006605 (2010).","DOI":"10.1002\/14651858.CD006605.pub2"},{"key":"54054_CR2","doi-asserted-by":"publisher","first-page":"e570","DOI":"10.1097\/PR9.0000000000000570","volume":"1","author":"C Rivat","year":"2016","unstructured":"Rivat, C. & Ballantyne, J. The dark side of opioids in pain management: basic science explains clinical observation. Pain Rep. 1, e570 (2016).","journal-title":"Pain Rep."},{"key":"54054_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neuroscience.2016.06.029","volume":"338","author":"L-A Roeckel","year":"2016","unstructured":"Roeckel, L.-A., Le Coz, G.-M., Gav\u00e9riaux-Ruff, C. & Simonin, F. Opioid-induced hyperalgesia: Cellular and molecular mechanisms. Neuroscience 338, 160\u2013182 (2016).","journal-title":"Neuroscience"},{"key":"54054_CR4","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/MJT.0b013e3181ed83a0","volume":"17","author":"MH Bekhit","year":"2010","unstructured":"Bekhit, M. H. Opioid-induced hyperalgesia and tolerance. Am. J. Ther. 17, 498\u2013510 (2010).","journal-title":"Am. J. Ther."},{"key":"54054_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/13543784.2018.1516204","volume":"27","author":"C Stein","year":"2018","unstructured":"Stein, C. New concepts in opioid analgesia. Expert Opin. Investig. Drugs 27, 765\u2013775 (2018).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"54054_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/bjp.2008.100","volume":"154","author":"MJ Christie","year":"2008","unstructured":"Christie, M. J. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br. J. Pharmacol. 154, 384\u2013396 (2008).","journal-title":"Br. J. Pharmacol."},{"key":"54054_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nm.4262","volume":"23","author":"G Corder","year":"2017","unstructured":"Corder, G. et al. Loss of \u03bc opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia. Nat. Med. 23, 164\u2013173 (2017).","journal-title":"Nat. Med."},{"key":"54054_CR8","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1113\/JP277428","volume":"597","author":"J Sun","year":"2019","unstructured":"Sun, J., Chen, S.-R., Chen, H. & Pan, H.-L. Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia. J. Physiol. 597, 1661\u20131675 (2019).","journal-title":"J. Physiol."},{"key":"54054_CR9","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1523\/JNEUROSCI.21-11-04074.2001","volume":"21","author":"E C\u00e9l\u00e8rier","year":"2001","unstructured":"C\u00e9l\u00e8rier, E., Laulin, J. P., Corcuff, J. B., Le Moal, M. & Simonnet, G. Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. J. Neurosci. Off. J. Soc. Neurosci. 21, 4074\u20134080 (2001).","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"54054_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000087658","volume":"14","author":"T King","year":"2005","unstructured":"King, T., Ossipov, M. H., Vanderah, T. W., Porreca, F. & Lai, J. Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance? Neurosignals 14, 194\u2013205 (2005).","journal-title":"Neurosignals"},{"key":"54054_CR11","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1124\/jpet.105.087254","volume":"314","author":"KM Raehal","year":"2005","unstructured":"Raehal, K. M., Walker, J. K. L. & Bohn, L. M. Morphine side effects in beta-arrestin 2 knockout mice. J. Pharmacol. Exp. Ther. 314, 1195\u20131201 (2005).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"54054_CR12","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/35047086","volume":"408","author":"LM Bohn","year":"2000","unstructured":"Bohn, L. M., Gainetdinov, R. R., Lin, F. T., Lefkowitz, R. J. & Caron, M. G. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408, 720\u2013723 (2000).","journal-title":"Nature"},{"key":"54054_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1124\/pr.112.005942","volume":"65","author":"JT Williams","year":"2013","unstructured":"Williams, J. T. et al. Regulation of \u03bc-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol. Rev. 65, 223\u2013254 (2013).","journal-title":"Pharmacol. Rev."},{"key":"54054_CR14","doi-asserted-by":"crossref","unstructured":"Adhikary, S. & Williams, J. T. Cellular Tolerance Induced by Chronic Opioids in the Central Nervous System. Front. Syst. Neurosci. 16, 937126 (2022).","DOI":"10.3389\/fnsys.2022.937126"},{"key":"54054_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ejphar.2008.02.013","volume":"584","author":"X Yue","year":"2008","unstructured":"Yue, X. et al. Sustained morphine treatment augments basal CGRP release from cultured primary sensory neurons in a Raf-1 dependent manner. Eur. J. Pharmacol. 584, 272\u2013277 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"54054_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/j.1460-9568.2009.06616.x","volume":"29","author":"C Rivat","year":"2009","unstructured":"Rivat, C. et al. Spinal NK-1 receptor-expressing neurons and descending pathways support fentanyl-induced pain hypersensitivity in a rat model of postoperative pain. Eur. J. Neurosci. 29, 727\u2013737 (2009).","journal-title":"Eur. J. Neurosci."},{"key":"54054_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pain.2006.09.033","volume":"129","author":"LP Vera-Portocarrero","year":"2007","unstructured":"Vera-Portocarrero, L. P. et al. Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways. Pain 129, 35\u201345 (2007).","journal-title":"Pain"},{"key":"54054_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0306-4522(00)00226-8","volume":"99","author":"W Ma","year":"2000","unstructured":"Ma, W., Zheng, W. H., Kar, S. & Quirion, R. Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons. Neuroscience 99, 529\u2013539 (2000).","journal-title":"Neuroscience"},{"key":"54054_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.1171759","volume":"325","author":"R Drdla","year":"2009","unstructured":"Drdla, R., Gassner, M., Gingl, E. & Sandk\u00fchler, J. Induction of synaptic long-term potentiation after opioid withdrawal. Science 325, 207\u2013210 (2009).","journal-title":"Science"},{"key":"54054_CR20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.tips.2016.08.002","volume":"37","author":"CM Cahill","year":"2016","unstructured":"Cahill, C. M., Walwyn, W., Taylor, A. M. W., Pradhan, A. A. A. & Evans, C. J. Allostatic Mechanisms of Opioid Tolerance Beyond Desensitization and Downregulation. Trends Pharmacol. Sci. 37, 963\u2013976 (2016).","journal-title":"Trends Pharmacol. Sci."},{"key":"54054_CR21","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41593-018-0144-y","volume":"21","author":"T-A Koshimizu","year":"2018","unstructured":"Koshimizu, T.-A. et al. Complex formation between the vasopressin 1b receptor, \u03b2-arrestin-2, and the \u03bc-opioid receptor underlies morphine tolerance. Nat. Neurosci. 21, 820\u2013833 (2018).","journal-title":"Nat. Neurosci."},{"key":"54054_CR22","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1073\/pnas.72.8.3092","volume":"72","author":"SK Sharma","year":"1975","unstructured":"Sharma, S. K., Klee, W. A. & Nirenberg, M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. USA. 72, 3092\u20133096 (1975).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"54054_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nn.3295","volume":"16","author":"F Ferrini","year":"2013","unstructured":"Ferrini, F. et al. Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl\u2212 homeostasis. Nat. Neurosci. 16, 183\u2013192 (2013).","journal-title":"Nat. Neurosci."},{"key":"54054_CR24","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1523\/JNEUROSCI.22-15-06747.2002","volume":"22","author":"LR Gardell","year":"2002","unstructured":"Gardell, L. R. et al. Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. J. Neurosci. Off. J. Soc. Neurosci. 22, 6747\u20136755 (2002).","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"54054_CR25","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1523\/JNEUROSCI.5530-09.2010","volume":"30","author":"EK Joseph","year":"2010","unstructured":"Joseph, E. K., Reichling, D. B. & Levine, J. D. Shared mechanisms for opioid tolerance and a transition to chronic pain. J. Neurosci. Off. J. Soc. Neurosci. 30, 4660\u20134666 (2010).","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"54054_CR26","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.tins.2009.07.007","volume":"32","author":"DB Reichling","year":"2009","unstructured":"Reichling, D. B. & Levine, J. D. Critical role of nociceptor plasticity in chronic pain. Trends Neurosci 32, 611\u2013618 (2009).","journal-title":"Trends Neurosci"},{"key":"54054_CR27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","volume":"10","author":"A Latremoliere","year":"2009","unstructured":"Latremoliere, A. & Woolf, C. J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J. Pain Off. J. Am. Pain Soc. 10, 895\u2013926 (2009).","journal-title":"J. Pain Off. J. Am. Pain Soc."},{"key":"54054_CR28","doi-asserted-by":"publisher","first-page":"7731","DOI":"10.1073\/pnas.96.14.7731","volume":"96","author":"DJ Mayer","year":"1999","unstructured":"Mayer, D. J., Mao, J., Holt, J. & Price, D. D. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc. Natl. Acad. Sci. USA. 96, 7731\u20137736 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"54054_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03496-2","volume":"9","author":"C Rivat","year":"2018","unstructured":"Rivat, C. et al. Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice. Nat. Commun. 9, 1042 (2018).","journal-title":"Nat. Commun."},{"key":"54054_CR30","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/j.pain.0000000000001155","volume":"159","author":"D Araldi","year":"2018","unstructured":"Araldi, D., Ferrari, L. F. & Levine, J. D. Role of GPCR (mu-opioid)-receptor tyrosine kinase (epidermal growth factor) crosstalk in opioid-induced hyperalgesic priming (type II). Pain 159, 864\u2013875 (2018).","journal-title":"Pain"},{"key":"54054_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nm.2633","volume":"18","author":"Y Wang","year":"2012","unstructured":"Wang, Y. et al. Blockade of PDGFR-\u03b2 activation eliminates morphine analgesic tolerance. Nat. Med. 18, 385\u2013387 (2012).","journal-title":"Nat. Med."},{"key":"54054_CR32","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/brain\/awl330","volume":"130","author":"SA Mousa","year":"2007","unstructured":"Mousa, S. A. et al. Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain J. Neurol. 130, 502\u2013513 (2007).","journal-title":"Brain J. Neurol."},{"key":"54054_CR33","doi-asserted-by":"publisher","first-page":"8802","DOI":"10.1016\/S0021-9258(18)81864-6","volume":"264","author":"DB Glass","year":"1989","unstructured":"Glass, D. B., Cheng, H. C., Mende-Mueller, L., Reed, J. & Walsh, D. A. Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. J. Biol. Chem. 264, 8802\u20138810 (1989).","journal-title":"J. Biol. Chem."},{"key":"54054_CR34","doi-asserted-by":"publisher","first-page":"11770","DOI":"10.1523\/JNEUROSCI.23-37-11770.2003","volume":"23","author":"Y Gao","year":"2003","unstructured":"Gao, Y., Nikulina, E., Mellado, W. & Filbin, M. T. Neurotrophins Elevate cAMP to Reach a Threshold Required to Overcome Inhibition by MAG through Extracellular Signal-Regulated Kinase-Dependent Inhibition of Phosphodiesterase. J. Neurosci. 23, 11770\u201311777 (2003).","journal-title":"J. Neurosci."},{"key":"54054_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0165-6147(90)90322-Y","volume":"11","author":"SM Crain","year":"1990","unstructured":"Crain, S. M. & Shen, K. F. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol. Sci. 11, 77\u201381 (1990).","journal-title":"Trends Pharmacol. Sci."},{"key":"54054_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejphar.2007.09.003","volume":"578","author":"VL Haller","year":"2008","unstructured":"Haller, V. L., Bernstein, M. A. & Welch, S. P. Chronic morphine treatment decreases the Cav1.3 subunit of the L-type calcium channel. Eur. J. Pharmacol. 578, 101\u2013107 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"54054_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0169-328X(96)00054-X","volume":"40","author":"N Matus-Leibovitch","year":"1996","unstructured":"Matus-Leibovitch, N. et al. Chronic morphine administration enhances the expression of Kv1.5 and Kv1.6 voltage-gated K+ channels in rat spinal cord. Brain Res. Mol. Brain Res. 40, 261\u2013270 (1996).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"54054_CR38","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/383819a0","volume":"383","author":"HW Matthes","year":"1996","unstructured":"Matthes, H. W. et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383, 819\u2013823 (1996).","journal-title":"Nature"},{"key":"54054_CR39","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/00000542-200310000-00041","volume":"99","author":"EM Pogatzki","year":"2003","unstructured":"Pogatzki, E. M. & Raja, S. N. A mouse model of incisional pain. Anesthesiology 99, 1023\u20131027 (2003).","journal-title":"Anesthesiology"},{"key":"54054_CR40","doi-asserted-by":"publisher","first-page":"102405","DOI":"10.1016\/j.pneurobio.2023.102405","volume":"222","author":"A Tassou","year":"2023","unstructured":"Tassou, A. et al. Activation of neuronal FLT3 promotes exaggerated sensorial and emotional pain-related behaviors facilitating the transition from acute to chronic pain. Prog. Neurobiol. 222, 102405 (2023).","journal-title":"Prog. Neurobiol."},{"key":"54054_CR41","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.jpain.2013.06.008","volume":"14","author":"NS Gregory","year":"2013","unstructured":"Gregory, N. S. et al. An overview of animal models of pain: disease models and outcome measures. J. Pain Off. J. Am. Pain Soc. 14, 1255\u20131269 (2013).","journal-title":"J. Pain Off. J. Am. Pain Soc."},{"key":"54054_CR42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ejphar.2015.05.014","volume":"763","author":"TF Brust","year":"2015","unstructured":"Brust, T. F., Conley, J. M. & Watts, V. J. G\u03b1(i\/o)-coupled receptor-mediated sensitization of adenylyl cyclase: 40 years later. Eur. J. Pharmacol. 763, 223\u2013232 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"54054_CR43","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0460-18.2020","volume":"7","author":"S Puig","year":"2020","unstructured":"Puig, S., Donica, C. L. & Gutstein, H. B. EGFR Signaling Causes Morphine Tolerance and Mechanical Sensitization in Rats. eNeuro 7, ENEURO.0460-18.2020 (2020).","journal-title":"eNeuro"},{"key":"54054_CR44","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrm1173","volume":"4","author":"R Wetzker","year":"2003","unstructured":"Wetzker, R. & B\u00f6hmer, F.-D. Transactivation joins multiple tracks to the ERK\/MAPK cascade. Nat. Rev. Mol. Cell Biol. 4, 651\u2013657 (2003).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"54054_CR45","doi-asserted-by":"publisher","first-page":"1059089","DOI":"10.3389\/fnsys.2022.1059089","volume":"16","author":"MC Gamble","year":"2022","unstructured":"Gamble, M. C. et al. Mu-opioid receptor and receptor tyrosine kinase crosstalk: Implications in mechanisms of opioid tolerance, reduced analgesia to neuropathic pain, dependence, and reward. Front. Syst. Neurosci. 16, 1059089 (2022).","journal-title":"Front. Syst. Neurosci."},{"key":"54054_CR46","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1056\/NEJMsr1706626","volume":"377","author":"ND Volkow","year":"2017","unstructured":"Volkow, N. D. & Collins, F. S. The Role of Science in the Opioid Crisis. N. Engl. J. Med. 377, 1798 (2017).","journal-title":"N. Engl. J. Med."},{"key":"54054_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.urolonc.2008.06.003","volume":"28","author":"MR Safarinejad","year":"2010","unstructured":"Safarinejad, M. R. Safety and efficacy of sorafenib in patients with castrate resistant prostate cancer: a Phase II study. Urol. Oncol. 28, 21\u201327 (2010).","journal-title":"Urol. Oncol."},{"key":"54054_CR48","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.71752","volume":"10","author":"MQ Nguyen","year":"2021","unstructured":"Nguyen, M. Q., von Buchholtz, L. J., Reker, A. N., Ryba, N. J. & Davidson, S. Single-nucleus transcriptomic analysis of human dorsal root ganglion neurons. eLife 10, e71752 (2021).","journal-title":"eLife"},{"key":"54054_CR49","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1097\/j.pain.0000000000001262","volume":"159","author":"A Drieu la Rochelle","year":"2018","unstructured":"Drieu la Rochelle, A. et al. A bifunctional-biased mu-opioid agonist-neuropeptide FF receptor antagonist as analgesic with improved acute and chronic side effects. Pain 159, 1705\u20131718 (2018).","journal-title":"Pain"},{"key":"54054_CR50","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/00000542-200002000-00029","volume":"92","author":"E C\u00e9l\u00e8rier","year":"2000","unstructured":"C\u00e9l\u00e8rier, E. et al. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 92, 465\u2013472 (2000).","journal-title":"Anesthesiology"},{"key":"54054_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/srep36407","volume":"6","author":"S Vent\u00e9o","year":"2016","unstructured":"Vent\u00e9o, S. et al. Fxyd2 regulates A\u03b4- and C-fiber mechanosensitivity and is required for the maintenance of neuropathic pain. Sci. Rep. 6, 36407 (2016).","journal-title":"Sci. Rep."},{"key":"54054_CR52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nprot.2008.223","volume":"4","author":"K Zimmermann","year":"2009","unstructured":"Zimmermann, K. et al. Phenotyping sensory nerve endings in vitro in the mouse. Nat. Protoc. 4, 174\u2013196 (2009).","journal-title":"Nat. Protoc."},{"key":"54054_CR53","volume":"35","author":"J Hao","year":"2021","unstructured":"Hao, J. et al. The widely used antihistamine mepyramine causes topical pain relief through direct blockade of nociceptor sodium channels. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 35, e22025 (2021).","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"54054_CR54","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1523\/JNEUROSCI.4584-05.2006","volume":"26","author":"C Torsney","year":"2006","unstructured":"Torsney, C. & MacDermott, A. B. Disinhibition Opens the Gate to Pathological Pain Signaling in Superficial Neurokinin 1 Receptor-Expressing Neurons in Rat Spinal Cord. J. Neurosci. 26, 1833\u20131843 (2006).","journal-title":"J. Neurosci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54054-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54054-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54054-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T08:06:08Z","timestamp":1730966768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54054-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54054"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54054-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3716184\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"6 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.S., L.D., J.B., and J.P.L. were full-time employees at Biodol Therapeutics. J.V. is inventor of patents (WO2011\/083124, WO2016\/016370, WO2017211937, EP2023\/0779572023) claiming the use of FLT3 inhibitors for the treatment of neuropathic pain and is co-founder of Biodol Therapeutics with P.S. and D.R. The other authors declare no conflict of interests related to the current investigation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9633"}}